GL1X · GenesisL1 explorer

UniProt Q8TDU6

G-protein coupled bile acid receptor 1 (Q8TDU6)

G-protein coupled bile acid receptor 1 (UniProt Q8TDU6): 7 experimental structures and 1 predicted model on GenesisL1, 5 ligands bound, 18 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
Q8TDU6
Protein
G-protein coupled bile acid receptor 1
Experimental structures
7
Predicted models
1
Ligands
5
Pockets
18 · 4 records with a druggable one

Structures

8 records of Q8TDU6 in the MolNFT archive: 7 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
7BW0Active human TGR5 complex with a synthetic agonist 23Helectron microscopyR——
7CFMCryo-EM structure of the P395-bound GPBAR-Gs complexelectron microscopyRFWX, CLR4 (best 0.83)
7CFMCryo-EM structure of the P395-bound gpbar-gs complexelectron microscopyRFWX, CLR—
7CFNCryo-EM structure of the INT-777-bound GPBAR-Gs complexelectron microscopyRFX0, CLR, PLM6 (best 0.79)
7CFNCryo-EM structure of the int-777-bound gpbar-gs complexelectron microscopyRFX0, CLR, PLM—
7XTQCryo-EM structure of the R399-bound GPBAR-Gs complexelectron microscopyRH8I5 (best 0.86)
7XTQCryo-EM structure of the R399-bound gpbar-gs complexelectron microscopyRH8I—
Q8TDU6AlphaFold monomer V2.0 prediction for G-protein coupled bile acid receptor 1 (Q8TDU6)predictedA—3 (best 0.80)

Ligands

  • CLR · Cholesterol · in 4 records
  • FWX · 2-(ethylamino)-6-[3-(4-propan-2-ylphenyl)propanoyl]-7, 8-dihydro-5H-pyrido[4,3-d]pyrimidine-4-carboxamide · in 2 records
  • FX0 · (2S,4R)-4-[(3R,5S,6R,7R,8R,9S,10S,12S,13R,14S,17R)-6-ethyl-10,13-dimethyl-3,7,12-tris(oxidanyl)-2,3,4,5,6, 7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-pentanoic acid · in 2 records
  • H8I · [2-(2,5-Dichloro-phenoxy)-pyridin-3-yl]-(3,4-dihydro-2H-quinolin-1-yl)-methanone · in 2 records
  • PLM · Palmitic acid · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.